Imaging mass spectrometry statistical analysis

Journal of Proteomics

Volumn 75, Issue 16, 2012, Pages 4962-4989

  Jones, Emrys A ^a   Deininger, Sören Oliver ^b   Hogendoorn, Pancras C W ^a   Deelder, André M ^a   McDonnell, Liam A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BRUKER DALTONIK GMBH   (Germany)

Author keywords

Biomarker discovery; Data analysis; Imaging mass spectrometry; Molecular histology

Indexed keywords

BIOLOGICAL MARKER;

ALGORITHM; CLUSTER ANALYSIS; DATA ANALYSIS; DATA PROCESSING; DISCRIMINANT ANALYSIS; HISTOLOGY; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MULTIVARIATE ANALYSIS; NONHUMAN; NONPARAMETRIC TEST; NORMAL DISTRIBUTION; PARAMETRIC TEST; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; REVIEW; TISSUE SECTION; UNIVARIATE ANALYSIS;

ANIMALS; DATA INTERPRETATION, STATISTICAL; DIAGNOSTIC IMAGING; HUMANS; MASS SPECTROMETRY; MODELS, BIOLOGICAL; REFERENCE STANDARDS; RESEARCH DESIGN;

EID: 84865161531     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.06.014     Document Type: Review

References (107)

1. Chaurand P., Sanders M.E., Jensen R.A., Caprioli R.M. Proteomics in diagnostic pathology - profiling and imaging proteins directly in tissue sections. Am J Pathol 2004, 165:1057-1068.
2. McDonnell L.A., Heeren R.M.A. Imaging mass spectrometry. Mass Spectrom Rev 2007, 26:606-643.
3. Schwamborn K., Caprioli R.M. Molecular imaging by mass spectrometry - looking beyond classical histology. Nat Rev Cancer 2010, 10:639-646.
4. Schwamborn K., Krieg R.C., Reska M., Jakse G., Knuechel R., Wellmann A. Identifying prostate carcinoma by MALDI-imaging. Int J Mol Med 2007, 20:155-159.
5. Balluff B., Rauser S., Meding S., Elsner M., Schoene C., Feuchtinger A., et al. MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer. Am J Pathol 2011, 179:2720-2729.
6. Alexandrov T., Becker M., Deininger S.-O., Grasmair G., von Eggeling F., Thiele H., et al. Spatial segmentation of imaging mass spectrometry with edge preserving image denoising and clustering. J Proteome Res 2010, 9:6535-6546.
7. Hanselmann M., Kothe U., Kirchner M., Renard B.Y., Amstalden E.R., Glunde K., et al. Toward digital staining using imaging mass spectrometry and random forests. J Proteome Res 2009, 8:3558-3567.
8. McDonnell L.A., van Remoortere A., van Zeijl R.J.M., Deelder A.M. Mass spectrometry image correlation: quantifying co-localization. J Proteome Res 2008, 7:3619-3627.
9. Jones E.A., van Remoortere A., van Zeijl R.J.M., Hogendoorn P.C.W., Boveé J.V.M.G., Deelder A.M., et al. Multiple statistical analysis techniques corroborate intratumor heterogeneity in imaging mass spectrometry datasets of myxofibrosarcoma. PLoS One 2011, 6:e24913.
10. Alexandrov T., Kobarg J.H. Efficient spatial segmentation of large imaging mass spectrometry datasets with spatially aware clustering. Bioinformatics 2011, 27:i230-i238.
11. Norris J.L., Cornett D.S., Mobley J.A., Andersson M., Seeley E.H., Chaurand P., et al. Processing MALDI mass spectra to improve mass spectral direct tissue analysis. Int J Mass Spectrom 2007, 260:212-221.
12. Guilliot S., Chaurand P., Stoeckli M., Caprioli R.M. Topographic imaging using time-of-flight mass spectrometry. 47th ASMS Conference. Dallas 1999.
13. McCombie G., Staab D., Stoeckli M., Knochenmuss R. Spatial and spectral correlations in MALDI mass spectrometry images by clustering and multivariate analysis. Anal Chem 2005, 77:6118-6124.
14. McDonnell L.A., Luxembourg S.L., Mize T.H., Koster S., Eijkel G.B., Verpoorte E., et al. Using matrix peaks to map topography: increased mass resolution and enhanced sensitivity in chemical imaging. Anal Chem 2003, 75:4373-4381.
15. McDonnell L.A., Piersma S.R., Altelaar A.F.M., Mize T.H., Luxembourg S.L., Verhaert P.D.E.M., et al. Subcellular imaging mass spectrometry of brain tissue. J Mass Spectrom 2005, 40:160-168.
16. Tracy M.B., Chen H., Weaver D.M., Malyarenko D.I., Sasinowski M., Cazares L.H., et al. Precision enhancement of MALDI-TOF MS using high resolution peak detection and label-free alignment. Proteomics 2008, 8:1530-1538.
17. Roempp A., Guenther S., Schober Y., Schulz O., Takats Z., Kummer W., et al. Histology by mass spectrometry: label-free tissue characterization obtained from high-accuracy bioanalytical imaging. Angew Chem Int Ed 2010, 49:3834-3838.
18. Villanueva J., Philip J., Chaparro C.A., Li Y., Toledo-Crow R., DeNoyer L., et al. Correcting common errors in identifying cancer-specific serum peptide signatures. J Proteome Res 2005, 4:1060-1072.
19. Yang J., Caprioli R.M. Matrix sublimation/recrystallization for imaging proteins by mass spectrometry at high spatial resolution. Anal Chem 2011, 83:5728-5734.
20. Lagarrigue M., Becker M., Lavigne R., Deininger S.-O., Walch A., Aubry F., et al. Revisiting rat spermatogenesis with MALDI imaging at 20μm resolution. Mol Cell Proteomics 2011, 10. [M110.005991].
21. Römpp A., Guenther S., Schober Y., Schultz O., Takats Z., Kummer W., et al. Histology by mass spectrometry: label-free tissue characterization obtained from high-accuracy bioanalytical imaging. Angew Chem Int Ed 2010, 49:3834-3838.
22. Luxembourg S.L., Mize T.H., McDonnell L.A., Heeren R.M.A. High-spatial resolution mass spectrometric imaging of peptide and protein distributions on a surface. Anal Chem 2004, 76:5339-5344.
23. Hopfgartner G., Varesio E., Stoeckli M. Matrix-assisted laser desorption/ionization mass spectrometric imaging of complete rat sections using a triple quadrupole linear ion trap. Rapid Commun Mass Spectrom 2009, 23:733-736.
24. Spraggins J.M., Caprioli R.M. High-speed MALDI-TOF imaging mass spectrometry: rapid ion image acquisition and considerations for next generation instrumentation. J Am Soc Mass Spectrom 2011, 22:1022-1031.
25. Wickes B.T., Kim Y., Castner D.G. Denoising and multivariate analysis of time-of-flight SIMS images. Surf Interface Anal 2003, 35:640-648.
26. Taban I.M., Altelaar A.F.M., Fuchser J., van der Burgt Y.E.M., McDonnell L.A., Baykut G., et al. Imaging of peptides in the rat brain using MALDI-FTICR mass spectrometry. J Am Soc Mass Spectrom 2006, 18:145-151.
27. McDonnell L.A., van Remoortere A., de Velde N., van Zeijl R.J.M., Deelder A. Imaging mass spectrometry data reduction: automated feature identification and extraction. J Am Soc Mass Spectrom 2010, 21:1969-1978.
28. Schober Y., Schramm T., Spengler B., Römpp A. Protein identification by accurate mass matrix-assisted laser desorption/ionization imaging of tryptic peptides. Rapid Commun Mass Spectrom 2011, 25:2475-2483.
29. Smith R.D. Evolution of ESI-mass spectrometry and Fourier transform ion cyclotron resonance for proteomics and other biological applications. Int J Mass Spectrom 2000, 200:509-544.
30. Shin H., Mutlu M., Koomen J.M., Markey M.K. Parametric power spectral density analysis of noise from instrumentation in MALDI ToF mass spectrometry. Cancer Inf 2007, 3:219-230.
31. Bouschen W., Spengler B. Artifacts of MALDI sample preparation investigated by high-resolution scanning microprobe matrix-assisted laser desorption/ionization (SMALDI) imaging mass spectrometry. Int J Mass Spectrom 2007, 266:129-137.
32. Luxembourg S.L., McDonnell L.A., Duursma M., Guo X., Heeren R.M.A. Effect of local matrix crystal variations in matrix-assisted ionization techniques for mass spectrometry. Anal Chem 2003, 75:2333-2341.
33. Du P., Stolovitzky G., Horvatovich P., Bischoff R., Lim J., Suits F. A noise model for mass spectrometry based proteomics. Bioinformatics 2008, 24:1070-1077.
34. Keenan M.R., Kotula P.G. Accounting for Poisson noise in the multivariate analysis of ToF-SIMS spectrum images. Surf Interface Anal 2004, 36:203-212.
35. Fonville J.M., Carter C., Cloarec O., Nicholson J.K., Lindon J.C., Bunch J., et al. Robust data processing and normalization strategy for MALDI mass spectrometric imaging. Anal Chem 2012, 84:1310-1319.
36. Lemaire R., Wisztorski M., Desmons A., Tabet J.C., Day R., Salzet M., et al. MALDI-MS direct tissue analysis of proteins: improving signal sensitivity using organic treatments. Anal Chem 2006, 78:7145-7153.
37. Seeley E.H., Oppenheimer S.R., Mi D., Chaurand P., Caprioli R.M. Enhancement of protein sensitivity for MALDI imaging mass spectrometry after chemical treatment of tissue sections. J Am Soc Mass Spectrom 2008, 19:1069-1077.
38. Cohen S., Chait B.T. Influence of matrix solution conditions on the MALDI-MS analysis of peptides and proteins. Anal Chem 1996, 68:31-37.
39. Domon B., Aebersold R. Options and considerations when selecting a quantitative proteomics strategy. Nat Biotechnol 2010, 28:710-721.
40. Stoeckli M., Staab D., Schweitzer A. Compound and metabolite distribution measured by MALDI mass spectrometric imaging in whole-body tissue sections. Int J Mass Spectrom 2007, 260:195-202.
41. Nilsson A., Fehniger T.E., Gustavsson L., Andersson M., Kenne K., Marko-Varga G., et al. Fine mapping the spatial distribution and concentration of unlabeled drugs within tissue micro-compartments using imaging mass spectrometry. PLoS One 2010, 5:e11411.
42. Deininger S.O., Cornett D.S., Paape R., Becker M., Pineau C., Rauser S., et al. Normalization in MALDI-TOF imaging datasets of proteins: practical considerations. Anal Bioanal Chem 2011, 401:167-181.
43. van Remoortere A., van Zeijl R., van den Oever N., Franck J., Longuespée R., Wisztorski M., et al. MALDI imaging and profiling MS of higher mass proteins from tissue. J Am Soc Mass Spectrom 2010, 21:1922-1929.
44. Broersen A., van Liere R., Altelaar A.F.M., Heeren R.M.A., McDonnell L.A. Automated, feature-based image alignment for high-resolution imaging mass spectrometry of large biological samples. J Am Soc Mass Spectrom 2008, 19:823-832.
45. van de Plas R. Tissue based proteomics and biomarker discovery: multivariate data mining strategies for mass spectral imaging 2010, Katholieke Universiteit Leuven, Leuven.
46. van de Plas R., de Moor B., Waelkens E. Discrete wavelet transform-based multivariate exploration of tissue via imaging mass spectrometry. Proceedings of the 23rd annual ACM symposium on applied computing. Fortaleza, Brazil 2008, 1307-1308.
47. Vogt F., Banerji S., Booksh K. Utilizing three-dimensional wavelet transforms for accelerated evaluation of hyperspectral image cubes. J Chemom 2004, 18:350-362.
48. Mantini D., Petrucci F., Pieragostino D., Del Boccio P., Di Nicola M., Di Ilio C., et al. LIMPIC: a computational method for the separation of protein MALDI-TOF-MS signals from noise. BMC Bioinformatics 2007, 8:101.
49. Jardin-Mathe O., Bonnel D., Franck J., Wisztorski M., Macagno E., Fournier I., et al. MITICS (MALDI Imaging Team Imaging Computing System): a new open source mass spectrometry imaging software. J Proteomics 2008, 71:332-345.
50. Balluff B., Elsner M., Kowarsch A., Rauser S., Meding S., Schumacher C., et al. Classification of HER2/neu status in gastric cancer using a breast-cancer derived proteome classifier. J Proteome Res 2010, 9:6317-6322.
51. Groseclose M.R., Massion P.P., Chaurand P., Caprioli R.M. High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry. Proteomics 2008, 8:3715-3724.
52. Rauser S., Marquardt C., Balluff B., Deininger S.O., Albers C., Belau E., et al. Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry. J Proteome Res 2010, 9:1854-1863.
53. Hardesty W.M., Kelley M.C., Mi D., Low R.L., Caprioli R.M. Protein signatures for survival and recurrence in metastatic melanoma. J Proteomics 2011, 74:1002-1014.
54. Reyzer M.L., Caldwell R.L., Dugger T.C., Forbes J.T., Ritter C.A., Guix M., et al. Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics. Cancer Res 2004, 64:9093-9100.
55. Cornett D.S., Mobley J.A., Dias E.C., Andersson M., Arteaga C.L., Sanders M.E., et al. A novel histology-directed strategy for MALDI-MS tissue profiling that improves throughput and cellular specificity in human breast cancer. Mol Cell Proteomics 2006, 5:1975-1983.
56. Bruand J., Sistla S., MeÉriaux Cl, Dorrestein P.C., Gaasterland T., Ghassemian M., et al. Automated querying and identification of novel peptides using MALDI mass spectrometric imaging. J Proteome Res 2011, 10:1915-1928.
57. Caldwell R.L., Gonzalez A., Oppenheimer S.R., Schwartz H.S., Caprioli R.M. Assessment of the tumor protein microenvironment using imaging mass spectrometry. Cancer Genomics Proteomics 2006, 3:279-288.
58. Oppenheimer S.R., Mi D., Sanders M.E., Caprioli R.M. Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma. J Proteome Res 2010, 9:2182-2190.
59. Kang S., Shim H.S., Lee J.S., Kim D.S., Kim H.Y., Hong S.H., et al. Molecular proteomics imaging of tumor interfaces by mass spectrometry. J Proteome Res 2010, 9:1157-1164.
60. Amstalden van Hove E.R., Blackwell T.R., Klinkert I., Eijkel G.B., Heeren R.M.A., Glunde K. Multimodal mass spectrometric imaging of small molecules reveals distinct spatio-molecular signatures in differentially metastatic breast tumor models. Cancer Res 2010, 70:9012-9021.
61. Willems S.M., van Remoortere A., van Zeijl R., Deelder A.M., McDonnell L.A., Hogendoorn P.C.W. Imaging mass spectrometry of myxoid sarcomas identifies proteins and lipids specific to tumor type and grade, and reveals biochemical intratumor heterogeneity. J Pathol 2010, 222:400-409.
62. Deininger S.-O., Ebert M.P., Fütterer A., Gerhard M., Röcken C. MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers. J Proteome Res 2008, 7:5230-5236.
63. Burnum K.E., Cornett D.S., Puolitaival S.M., Milne S.B., Myers D.S., Tranguch S., et al. Spatial and temporal alterations of phospholipids determined by mass spectrometry during mouse embryo implantation. J Lipid Res 2009, 50:2290-2298.
64. Urban P.L., Chang C.-H., Wu J.-T., Chen Y.-C. Microscale MALDI imaging of outer-layer lipids in intact egg chambers from Drosophila melanogaster. Anal Chem 2011, 83:3918-3925.
65. Mathur B.N., Caprioli R.M., Deutch A.Y. Proteomic analysis illuminates a novel structural definition of the claustrum and insula. Cereb Cortex 2009, 19:2372-2379.
66. Caldwell R.L., Opalenik S.R., Davidson J.M., Caprioli R.M., Nanney L.B. Tissue profiling MALDI mass spectrometry reveals prominent calcium-binding proteins in the proteome of regenerative MRL mouse wounds. Wound Repair Regen 2008, 16:442-449.
67. Meriaux C., Arafah K., Tasiemski A., Wisztorski M., Bruand J., Wichlacz-Boidin C., et al. Multiple changes in peptide and lipid expression associated with regeneration in the nervous system of the medicinal leech. PLoS One 2011, 6:e18359.
68. Taverna D., Nanney L.B., Pollins A.C., Sindona G., Caprioli R. Multiplexed molecular descriptors of pressure ulcers defined by imaging mass spectrometry. Wound Repair Regen 2011, 19:734-744.
69. Guillou L., Coindre J.M., Bonichon F., Nguyen B.B., Terrier P., Collin F., et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 1997, 15:350-362.
70. Mentzel T., van den Berg E., Molenaar W.M. Myxofibrosarcoma. World Health Organization classification of tumours pathology and genetics tumours of soft tissue and bone 2004, 102-103. IARC Press, Lyon. 2002 ed. C.D.M. Fletcher, K.K. Unni, F. Mertens (Eds.).
71. Klerk L.A., Broersen A., Fletcher I.W., van Liere R., Heeren R.M.A. Extended data analysis strategies for high resolution imaging MS: new methods to deal with extremely large image hyperspectral datasets. Int J Mass Spectrom 2007, 260:222-236.
72. Kargacin M.E., Kowalski B.R. Ion intensity and image resolution in secondary ion mass spectrometry. Anal Chem 1986, 58:2300-2306.
73. Graham D. Multivariate surface analysis homepage http://mvsa.nb.uw.edu.
74. McDonnell L.A., Willems S.M., Corthals G.L., van Remoortere A., van Zeijl R.J.M., Deelder A.M. Imaging mass spectrometry in cancer research: past experiences and future possibilities. J Proteomics 2010, 73:1921-1944.
75. Fletcher J.S., Rabbani S., Henderson A., Lockyer N.P., Vickerma J.C. Three-dimensional mass spectral imaging of HeLa-M cells - sample preparation, data interpretation and visualisation. Rapid Commun Mass Spectrom 2011, 25:925-993.
76. Tyler B.J., Rayal G., Castner D.G. Multivariate analysis strategies for processing ToF-SIMS images of biomaterials. Biomaterials 2007, 28:2412-2423.
77. Broersen A., van Liere R., Heeren R.M.A. Parametric visualization of high resolution correlated multi-spectral features using PCA. Eurovis 2007 2007, Norrköping.
78. Schwartz S.A., Weil R.J., Johnson M.D., Toms S.A., Caprioli R.M. Protein profiling in brain tumors using mass spectrometry: feasibility of a new technique for the analysis of protein expression. Clin Cancer Res 2004, 10:981-987.
79. Bonnel D., Longuespee R., Franck J., Roudbaraki M., Gosset P., Day R., et al. Multivariate analyses for biomarkers hunting and validation through on-tissue bottom-up or in-source decay in MALDI-MSI: application to prostate cancer. Anal Bioanal Chem 2011, 401:149-165.
80. Dunn J.C. A fuzzy relative of the ISODATA process and its use in detecting compact well-separated clusters. J Cybern 1973, 3:32-57.
81. Bruand J., Alexandrov T., Sistla S., Wisztorski M., MeÉriaux Cl, Becker M., et al. AMASS: algorithm for MSI analysis by semi-supervised segmentation. J Proteome Res 2011, 10:4734-4743.
82. Lee D.D., Seung H.S. Learning the parts of objects by non-negative matrix factorization. Nature 1999, 401:788-791.
83. Jones E.A., RJMv Zeijl, Deelder A.M., Andrén P.E., Wolters L., McDonnell L.A. High speed data processing for imaging MS-based molecular histology using graphical processing units. J Am Soc Mass Spectrom 2012, 23:745-752.
84. Hanselmann M., Kirchner M., Renard B.Y., Amstalden E.R., Glunde K., Heeren R.M.A., et al. Concise representation of mass spectrometry images by probabilistic latent semantic analysis. Anal Chem 2008, 80:9649-9658.
85. Andersson M., Groseclose M.R., Deutch A.Y., Caprioli R.M. Imaging mass spectrometry of proteins and peptides: 3D volume reconstruction. Nat Methods 2008, 5:101-108.
86. Crecelius A.C., Williams B., Cornett D.S., Li X., Dawant B.M., Bodenheimer R.E., et al. Reconstructing and visualizing protein distributions in 3-D by MALDI imaging mass spectrometry. 52nd ASMS conference. Nashville, TN 2004.
87. Sinha T.K., Khatib-Shahidi S., Yankeelov T.E., Mapara K., Ehtesham M., Cornett D.S., et al. Integrating spatially resolved three dimensional MALDI IMS with in vivo magnetic resonance imaging. Nat Methods 2008, 5:57-59.
88. Smentkowski V.S., Ostrowski S.G., Braunstein E., Keenan M.R., Ohlhausen J.A.T., Kotula P.G. Multivariate statistical analysis of three-spatial-dimension TOF-SIMS raw data sets. Anal Chem 2007, 79:7719-7726.
89. Keenan M.R., Smentkowski V.S., Ulfig R.M., Oltman E., Larson D.J., Kelly T.F. Atomic-scale phase composition through multivariate statistical analysis of atom probe tomography data. Microsc Microanal 2011, 17:418-430.
90. Scholz B., Sköld K., Kultima K., Fernandez C., Waldemarson S., Savitski M.M., et al. Impact of temperature dependent sampling procedures in proteomics and peptidomics - a characterization of the liver and pancreas post mortem degradome. Mol Cell Proteomics 2011, 10.
91. Svensson M., Boren M., Skold K., Falth M., Sjogren B., Andersson M., et al. Heat stabilization of the tissue proteome: a new technology for improved proteomics. J Proteome Res 2009, 8:974-981.
92. Goodwin R.J.A., Dungworth J.C., Cobb S.R., Pitt A.R. Time-dependent evolution of tissue markers by MALDI-MS imaging. Proteomics 2008, 8:3801-3808.
93. Goodwin R.J.A., Iverson S.L., Andren P.E. The significance of ambient-temperature on pharmaceutical and endogenous compound abundance and distribution in tissues sections when analyzed by matrix-assisted laser desorption/ionization mass spectrometry imaging. Rapid Commun Mass Spectrom 2012, 26:494-498.
94. Goodwin R.J.A. Sample preparation for mass spectrometry imaging: Small mistakes can lead to big consequences. J Proteomics 2012, 75:4893-4911. (this issue).
95. McDonnell L.A., Corthals G.C., Andrén P.E. Going forward: Increasing the accessibility of imaging mass spectrometry. J Proteomics 2012, 75:5113-5121. (this issue).
96. Cazares L.H., Troyer D., Mendrinos S., Lance R.A., Nyalwidhe J.O., Beydoun H.A., et al. Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue. Clin Cancer Res 2009, 15:5541-5551.
97. Hauskrecht M., Pelikan R., Valko M., James, Lyons-Weiler Feature selection and dimensionality reduction in genomics and proteomics. Fundamentals of data mining in genomics and proteomics 2007, 149-172. Springer. W. Dubitzky, M. Granzow, D.P. Berrar (Eds.).
98. Manly K.F., Nettleton D., Hwang J.T. Genomics, prior probability, and statistical tests of multiple hypotheses. Genome Res 2004, 14:997-100.
99. Ting L., Cowley M.J., Hoon S.L., Guilhaus M., Raftery M.J., Cavicchioli R. Normalization and statistical analysis of quantitative proteomics data generated by metabolic labeling* Mol Cell Proteomics 2009, 8:2227-2242.
100. Karp N.A., Spencer M., Lindsay H., O'Dell K., Lilley K.S. Impact of replicate types on proteomic expression analysis. J Proteome Res 2005, 4:1867-1871.
101. Djidja M.-C., Claude E., Snel M.F., Francese S., Scriven P., Carolan V., et al. Novel molecular tumour classification using MALDI-mass spectrometry imaging of tissue micro-array. Anal Bioanal Chem 2010, 397:587-601.
102. Meding S., Nitsche U., Balluff B., Elsner M., Rauser S., Schöne C., et al. Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging. J Proteome Res 2012, 11:1996-2003.
103. Hilario M., Kalousis A., Pellegrini C., Müller M. Processing and classification of protein mass spectra. Mass Spectrom Rev 2006, 25:409-449.
104. Lazova R., Seeley E.H., Keenan M., Gueorguieva R., Caprioli R.M. Imaging mass spectrometry-a new and promising method to differentiate spitz nevi from spitzoid malignant melanomas. Am J Dermatopathol 2012, 34:82-90.
105. Umar A., Kang H., Timmermans A.M., Annemieke M., Look M.P., Meijer-van Gelder M.E., et al. Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer. Mol Cell Proteomics 2009, 8:1278-1294.
106. Waanders L.F., Chwalek K., Monetti M., Kumar C., Lammert E., Mann M. Quantitative proteomic analysis of single pancreatic islets. PNAS 2009, 106:18902-18907.
107. Stoeckli M., Staab D., Schweitzer A. Compound and metabolite distribution measured by MALDI mass spectrometric imaging in whole-body tissue sections. Int J Mass Spectrom 2007, 260:195-202.